Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about GSK
Recent news which mentions GSK
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
U.S. stock futures point to modest gains after powerful start to the week
December 08, 2021
Tickers
COMP
GSK
SFIX
SPX
Tags
SFIX
DJIA
ES00
From
MarketWatch
Why Amazon Stock Was Higher Today
December 07, 2021
Tickers
AMZN
COST
GSK
UBS
Tags
UBS
AMZN
COST
From
Motley Fool
Cramer Gives His Opinion On GlaxoSmithKline, Asana And More
December 07, 2021
Tickers
ASAN
CRM
DOCS
GSK
Tags
Benzinga
Trading Ideas
Long Ideas
From
Benzinga
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021
Tickers
GSK
LLY
REGN
VIR
Tags
REGN
GSK
LLY
From
MarketWatch
Investors Do A Little Holiday Value Shopping On Monday
December 07, 2021
Tickers
AAPL
GSK
INTC
MRNA
Tags
Health Care
Earnings
NCLH
From
Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
Tickers
ACAD
APTX
AZN
BLU
Tags
Penny Stocks
DARE
CYTK
From
Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Tickers
GSK
Tags
News
Biotech
COVID/19 Vaccine
From
Benzinga
Preclinical Data Shows GSK-Vir COVID-19 Drug Works Against All Omicron Mutations
December 07, 2021
Tickers
GSK
VIR
Tags
Briefs
VIR
GSK
From
Benzinga
Dow futures jump nearly 300 points as rebound from omicron worries continues
December 07, 2021
Tickers
COMP
GSK
INTC
SPX
Tags
ES00
DJIA
INTC
From
MarketWatch
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
Tickers
AMGN
BMY
GSK
Tags
BMY
AMGN
Market News
From
Motley Fool
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
Tickers
ADAP
AGEN
ALPMY
GSK
Tags
OCGN
ADAP
ALPMY
From
Motley Fool
Why Jim Cramer Likes Enbridge, Vir Biotechnology And More
December 03, 2021
Tickers
ENB
GSK
HOOD
ON
Tags
VIR
GSK
Media
From
Benzinga
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
Tickers
AI
AUPH
BMY
GSK
Tags
GSK
NASDAQ:AUPH,NYSE:NVS,NYSE:BMY,NYSE:GSK,NYSE:TWTR,NYSE:SQ,NYSE:AI
SQ
From
InvestorPlace
White House plans at-home COVID-19 testing blitz for winter, and Germany to lock down its unvaccinated
December 02, 2021
Tickers
GSK
VIR
Tags
VIR
UK:GSK
GSK
From
MarketWatch
Apple Issues Negative iPhone 13 Forecast as Boeing Gets "Okay" from China
December 02, 2021
Tickers
AAPL
BA
GSK
SNOW
Tags
VIR
GSK
Government
From
Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Tickers
ACST
AMGN
BNTX
CMMB
Tags
Small Cap
PFE
Biotech
From
Benzinga
The omicron panic is overdone. Buy the dips in these stocks, says JPMorgan.
December 02, 2021
Tickers
AAPL
GME
GSK
TSLA
Tags
UK:GSK
GME
TSLA
From
MarketWatch
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
December 02, 2021
Tickers
GSK
VBIV
Tags
News
Biotech
General
From
Benzinga
Britain Agrees To New Deals For 114M Additional Moderna, Pfizer/BioNTech COVID-19 Vaccine Doses
December 02, 2021
Tickers
BNTX
GSK
MRNA
NVAX
Tags
Health Care
Contracts
BNTX
From
Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
Tickers
GSK
MRK
VIR
Tags
Health Care
MRK
GSK
From
Benzinga
Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
December 01, 2021
Tickers
BNTX
GSK
MRNA
PFE
Tags
General
Biotech
News
From
Benzinga
Why Did HC Wainwright Beef Up Vir Biotech's Target Price?
November 30, 2021
Tickers
GSK
VIR
Tags
Movers
Market News
Analyst Ratings
From
Benzinga
Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb
November 30, 2021
Tickers
BMY
GSK
Tags
BMY
GSK
Recent Press Releases
From
Motley Fool
FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
November 30, 2021
Tickers
GILD
GSK
LLY
MRK
Tags
VIR
MRK
GILD
From
MarketWatch
VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.
November 30, 2021
Tickers
GSK
VIR
Tags
Market News
GSK
NASADAQ:VIR,NYSE:GSK
From
InvestorPlace
3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries
November 29, 2021
Tickers
ADGI
AZN
GSK
LLY
Tags
Trading Ideas
PFE
LLY
From
Benzinga
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
November 29, 2021
Tickers
ADPT
EXAS
GSK
SURF
Tags
EXAS
Market News
ADPT
From
Motley Fool
1 High-Yield Dividend Stock Worth Buying Right Now
November 28, 2021
Tickers
GSK
Tags
Recent Press Releases
Market News
GSK
From
Motley Fool
Who Would Be the Best FDA Commissioner for Biotech Investors?
November 28, 2021
Tickers
GOOG
GOOGL
GSK
JNJ
Tags
MRK
Recent Press Releases
GOOGL
From
Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
Tickers
AZN
BNTX
GSK
JNJ
Tags
UK:AZN
JNJ
BNTX
From
MarketWatch
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.